Fulgent Genetics (FLGT) Notes Payables (2020 - 2026)

Fulgent Genetics has reported Notes Payables for 6 years, with the latest figure at $482000.0 in Q2 2026.

• Quarterly Notes Payables rose 1.26% year-over-year to $482000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $482000.0 (up 1.26% YoY) and the FY2025 annual result came in at $476000.0, up 15.53% from the prior year.
• Notes Payables was little changed at $482000.0 in Q2 2026 per FLGT's latest filing, from $482000.0 in the prior quarter.
• Over five years, Notes Payables peaked at $6.1 million in Q1 2022 and troughed at $412000.0 in Q2 2024.
• A 5-year average of $2.3 million and a median of $482000.0 in 2026 frame the typical range for Notes Payables.
• The sharpest annual moves came in 2024 and 2025: Notes Payables sank 92.64% in 2024, then climbed 15.53% in 2025.
• Over 5 years, Notes Payables stood at $5.6 million in 2022, then sank by 79.02% to $1.2 million in 2023, then slumped by 65.17% to $412000.0 in 2024, then rose by 15.53% to $476000.0 in 2025, then gained by 1.26% to $482000.0 in 2026.
• According to Business Quant data, Notes Payables over the past three periods registered $482000.0, $482000.0, and $476000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.